360 related articles for article (PubMed ID: 9412458)
1. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
Sternsdorf T; Jensen K; Will H
J Cell Biol; 1997 Dec; 139(7):1621-34. PubMed ID: 9412458
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization, expression, and structure of the nuclear dot protein 52.
Sternsdorf T; Jensen K; Züchner D; Will H
J Cell Biol; 1997 Jul; 138(2):435-48. PubMed ID: 9230084
[TBL] [Abstract][Full Text] [Related]
3. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
Chelbi-Alix MK; de Thé H
Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
[TBL] [Abstract][Full Text] [Related]
4. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
[TBL] [Abstract][Full Text] [Related]
5. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional heterogeneity of nuclear bodies.
Bloch DB; Chiche JD; Orth D; de la Monte SM; Rosenzweig A; Bloch KD
Mol Cell Biol; 1999 Jun; 19(6):4423-30. PubMed ID: 10330182
[TBL] [Abstract][Full Text] [Related]
7. Role of SUMO-1-modified PML in nuclear body formation.
Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
[TBL] [Abstract][Full Text] [Related]
8. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
[TBL] [Abstract][Full Text] [Related]
9. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
Engelhardt OG; Ullrich E; Kochs G; Haller O
Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
[TBL] [Abstract][Full Text] [Related]
10. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation.
Duprez E; Saurin AJ; Desterro JM; Lallemand-Breitenbach V; Howe K; Boddy MN; Solomon E; de Thé H; Hay RT; Freemont PS
J Cell Sci; 1999 Feb; 112 ( Pt 3)():381-93. PubMed ID: 9885291
[TBL] [Abstract][Full Text] [Related]
11. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.
Müller S; Dejean A
J Virol; 1999 Jun; 73(6):5137-43. PubMed ID: 10233977
[TBL] [Abstract][Full Text] [Related]
12. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML).
Grötzinger T; Sternsdorf T; Jensen K; Will H
Eur J Biochem; 1996 Jun; 238(2):554-60. PubMed ID: 8681971
[TBL] [Abstract][Full Text] [Related]
13. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.
Ishov AM; Sotnikov AG; Negorev D; Vladimirova OV; Neff N; Kamitani T; Yeh ET; Strauss JF; Maul GG
J Cell Biol; 1999 Oct; 147(2):221-34. PubMed ID: 10525530
[TBL] [Abstract][Full Text] [Related]
14. Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection.
Puvion-Dutilleul F; Venturini L; Guillemin MC; de Thé H; Puvion E
Exp Cell Res; 1995 Dec; 221(2):448-61. PubMed ID: 7493645
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
[TBL] [Abstract][Full Text] [Related]
16. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100.
Negorev D; Ishov AM; Maul GG
J Cell Sci; 2001 Jan; 114(Pt 1):59-68. PubMed ID: 11112690
[TBL] [Abstract][Full Text] [Related]
17. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers.
Sternsdorf T; Jensen K; Reich B; Will H
J Biol Chem; 1999 Apr; 274(18):12555-66. PubMed ID: 10212234
[TBL] [Abstract][Full Text] [Related]
18. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
[TBL] [Abstract][Full Text] [Related]
19. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis.
Sternsdorf T; Guldner HH; Szostecki C; Grötzinger T; Will H
Scand J Immunol; 1995 Aug; 42(2):257-68. PubMed ID: 7631159
[TBL] [Abstract][Full Text] [Related]
20. Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.
Seeler JS; Marchio A; Losson R; Desterro JM; Hay RT; Chambon P; Dejean A
Mol Cell Biol; 2001 May; 21(10):3314-24. PubMed ID: 11313457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
